Highly sensitive immunoassay for rapid quantification of meningococcal capsular polysaccharide antigens

The present disclosure relates to the field of immunoassays for Gram negative bacteria, in particular N. meningitidis. The disclosure provides a simple and affordable immunoassay to quantitate polysaccharides in meningococcal vaccines for the evaluation of antigen content and lot-to-lot manufacturin...

Full description

Saved in:
Bibliographic Details
Main Authors Jagdishprasad, Gairola Sunil, Manohar, Kale Sameer, Keshav, Sharma Pankaj
Format Patent
LanguageEnglish
Published 30.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to the field of immunoassays for Gram negative bacteria, in particular N. meningitidis. The disclosure provides a simple and affordable immunoassay to quantitate polysaccharides in meningococcal vaccines for the evaluation of antigen content and lot-to-lot manufacturing consistency. The inventors have found a Sandwich ELISA that can be applicable for the quantitation and identification of N. meningitidis serogroup X polysaccharide in a multivalent meningococcal polysaccharide-protein conjugate vaccine as well as in a multivalent meningococcal plain polysaccharide vaccine. Said assay employs a polyclonal antibody as capture antibody and a novel monoclonal antibody against serogroup X polysaccharide as detection antibody. Further the assay is rapid, robust and reproducible.
Bibliography:Application Number: US201514808352